Zensar acquires BridgeView to expand into biopharma, life sciences industry

Pune-headquartered IT company Zensar Technologies announced the acquisition of pharma and life sciences consulting firm BridgeView Lifesciences for a total deal value of $25 million.

This will allow the firm to expand its healthcare offerings.

“The company will make an aggregate upfront payment of $14 million subject to customary adjustments for working capital, debt and cash on closing, and an additional payment of up to $11 million by December 31, 2027, contingent on achievement of performance and employment continuity thresholds,” it said in a regulatory filing to the Bombay Stock Exchange.